
SpringWorks Therapeutics Inc
NASDAQ:SWTX

Intrinsic Value
The intrinsic value of one
SWTX
stock under the Base Case scenario is
45
USD.
Compared to the current market price of 49.77 USD,
SpringWorks Therapeutics Inc
is
Overvalued by 10%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
SpringWorks Therapeutics Inc
Fundamental Analysis


Revenue & Expenses Breakdown
SpringWorks Therapeutics Inc
Balance Sheet Decomposition
SpringWorks Therapeutics Inc
Current Assets | 380.5m |
Cash & Short-Term Investments | 308m |
Receivables | 46.2m |
Other Current Assets | 26.2m |
Non-Current Assets | 206.8m |
Long-Term Investments | 158.1m |
PP&E | 26.7m |
Other Non-Current Assets | 22m |
Free Cash Flow Analysis
SpringWorks Therapeutics Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
SpringWorks Therapeutics Inc
Revenue
|
191.6m
USD
|
Cost of Revenue
|
-12.6m
USD
|
Gross Profit
|
179m
USD
|
Operating Expenses
|
-457.2m
USD
|
Operating Income
|
-278.1m
USD
|
Other Expenses
|
20m
USD
|
Net Income
|
-258.1m
USD
|
SWTX Profitability Score
Profitability Due Diligence
SpringWorks Therapeutics Inc's profitability score is 28/100. The higher the profitability score, the more profitable the company is.

Score
SpringWorks Therapeutics Inc's profitability score is 28/100. The higher the profitability score, the more profitable the company is.
SWTX Solvency Score
Solvency Due Diligence
SpringWorks Therapeutics Inc's solvency score is 80/100. The higher the solvency score, the more solvent the company is.

Score
SpringWorks Therapeutics Inc's solvency score is 80/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
SWTX Price Targets Summary
SpringWorks Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
SWTX
is 75.77 USD
with a low forecast of 65.65 USD and a high forecast of 91.35 USD.
Dividends
Current shareholder yield for SWTX is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
SWTX
stock under the Base Case scenario is
45
USD.
Compared to the current market price of 49.77 USD,
SpringWorks Therapeutics Inc
is
Overvalued by 10%.